Zahinoor Ismail
YOU?
Author Swipe
View article: The impact of anticholinergic burden on the development of mild behavioral impairment
The impact of anticholinergic burden on the development of mild behavioral impairment Open
Structured Abstract Objective Mild Behavioral Impairment (MBI) is a syndrome of late-life-onset persistent neuropsychiatric symptoms. Anticholinergic medication is commonly prescribed in older adults. Both MBI and anticholinergic exposure …
View article: Plasma biomarkers in neuropsychiatric syndromes: A narrative review
Plasma biomarkers in neuropsychiatric syndromes: A narrative review Open
Neuropsychiatric symptoms (NPS) are common features of neurodegenerative disease (NDD) but are relatively understudied compared to cognition, especially regarding biomarkers. Further, emerging evidence describes the utility of systematic a…
View article: Drug repurposing for Alzheimer’s disease: a Delphi consensus and stakeholder consultation
Drug repurposing for Alzheimer’s disease: a Delphi consensus and stakeholder consultation Open
View article: Acceptability and Feasibility of a Sensor-Instrumented ‘SmartSocks’ Wearable Prototype to Detect Agitation in People with Dementia
Acceptability and Feasibility of a Sensor-Instrumented ‘SmartSocks’ Wearable Prototype to Detect Agitation in People with Dementia Open
Background: Objective measurement of agitation in dementia could address the limitations of questionnaire-based assessments and support timely, person-centred interventions. ‘SmartSocks’ (Milbotix Ltd) is a novel wearable device that recor…
View article: Sex Differences in Phenomenology of Behavioral and Psychological Symptoms of Dementia
Sex Differences in Phenomenology of Behavioral and Psychological Symptoms of Dementia Open
Introduction: Behavioral and psychological symptoms in dementia (BPSD) are highly prevalent in patients with Alzheimer’s dementia (AD). We examined sex differences in the frequency and severity of BPSD in patients with AD living in long-te…
View article: Culturally sensitive CLEAR guidelines on disclosing and communicating a diagnosis of dementia
Culturally sensitive CLEAR guidelines on disclosing and communicating a diagnosis of dementia Open
Providing a dementia diagnosis is challenging, especially in primary care and considering diverse patient backgrounds. The Alzheimer Society of Canada (ASC), the College of Family Physicians of Canada, and the Canadian Consensus Conference…
View article: Acceptability and feasibility of a sensor-instrumented ‘SmartSocks’ wearable prototype to detect agitation in people with dementia
Acceptability and feasibility of a sensor-instrumented ‘SmartSocks’ wearable prototype to detect agitation in people with dementia Open
View article: The cross-sectional associations between enlarged perivascular spaces and mild behavioral impairment in dementia-free older adults
The cross-sectional associations between enlarged perivascular spaces and mild behavioral impairment in dementia-free older adults Open
Background Enlarged perivascular spaces (EPVS) and mild behavioral impairment (MBI) are associated with greater dementia risk. Objective We investigated cross-sectional associations between EPVS burden and MBI presence and symptom severity…
View article: Validation of the Care Partner Stress Scale in the CAN-PROTECT Study
Validation of the Care Partner Stress Scale in the CAN-PROTECT Study Open
Background Family and friend care partners play a vital role in supporting individuals with neurocognitive disorders, such as Alzheimer disease and related dementias. Care partners are often uncompensated and face unique, multifaceted chal…
View article: Cognitive reserve as a moderator of the association between brain structure and later-life behavioural symptoms across the neurocognitive spectrum
Cognitive reserve as a moderator of the association between brain structure and later-life behavioural symptoms across the neurocognitive spectrum Open
INTRODUCTION Cognitive reserve (CR) may buffer against the clinical manifestations of neurodegenerative disease. However, less is known about the relationship between CR and neuropsychiatric symptoms (NPS). Here, we investigated the modera…
View article: Validation of the Quality of Life and Function Five Domain Scale (QFS-5) against the EuroQol-5D (EQ-5D)
Validation of the Quality of Life and Function Five Domain Scale (QFS-5) against the EuroQol-5D (EQ-5D) Open
INTRODUCTION: Quality of life (QoL) captures objective life conditions, subjective wellbeing, and personal aspirations. There is growing interest in ability-based, patient-centred instruments that are not confounded by health outcomes. The…
View article: New landscape of the diagnosis of Alzheimer's disease
New landscape of the diagnosis of Alzheimer's disease Open
Alzheimer's disease involves a drastic departure from the cognitive, functional, and behavioural trajectory of normal ageing, and is both a dreaded and highly prevalent cause of disability to individuals, and a leading source of health and…
View article: Treatment for Alzheimer's disease
Treatment for Alzheimer's disease Open
Over the last three decades, the evidence on how to best treat the cognitive and non-cognitive symptoms of patients with Alzheimer's disease has increased. Although these pharmacological and non-pharmacological strategies have significantl…
View article: Creating a Clinical Care Pathway for Depressive Symptoms and Disorders in Long-Term Care: A Modified Delphi Process
Creating a Clinical Care Pathway for Depressive Symptoms and Disorders in Long-Term Care: A Modified Delphi Process Open
The generated statements provide steps for identifying and managing depression among residents of LTC. These steps can be further tested in practice Canada-wide to improve care for residents. Steps that detail care outside current practice…
View article: Enhancing Alzheimer Disease Detection Using Neuropsychiatric Symptoms: The Role of Mild Behavioural Impairment in the Revised NIA-AA Research Framework
Enhancing Alzheimer Disease Detection Using Neuropsychiatric Symptoms: The Role of Mild Behavioural Impairment in the Revised NIA-AA Research Framework Open
Background As the prevalence of Alzheimer disease (AD) rises, early identification of at-risk individuals is essential for effective intervention. Mild behavioral impairment (MBI), which captures emergent and persistent neuropsychiatric sy…
View article: Understanding difficulty in transitioning from residency to independent practice in pathology
Understanding difficulty in transitioning from residency to independent practice in pathology Open
A web-based survey of 118 pathologists was used to determine the incidence of difficulty transitioning from residency to independent practice. The underlying themes associated with difficulty were further explored through semi-structured i…
View article: The Mild Behavioral Impairment Checklist for Parkinson's Disease: An Ancillary Instrument in Cognitive Assessment
The Mild Behavioral Impairment Checklist for Parkinson's Disease: An Ancillary Instrument in Cognitive Assessment Open
Background Mild behavioral impairment (MBI) is a syndrome characterized by the later‐life onset of neuropsychiatric symptoms (NPS) and serves as a potential marker for dementia. In Parkinson's disease (PD), MBI has been associated with wor…
View article: Patient-reported efficacy of adjunctive brexpiprazole in major depressive disorder in a phase 4, open-label, interventional study
Patient-reported efficacy of adjunctive brexpiprazole in major depressive disorder in a phase 4, open-label, interventional study Open
Patient-reported diary data revealed early and sustained improvements in depressive symptom severity during 8 weeks of adjunctive brexpiprazole treatment. 'Word of the day' may be an effective qualitative tool for future trials.
View article: Recommendations for management and future investigation of psychosis in neurodegenerative disease: Findings from the International Psychogeriatric Association (IPA) working group
Recommendations for management and future investigation of psychosis in neurodegenerative disease: Findings from the International Psychogeriatric Association (IPA) working group Open
Future directions include the need for the implementation of evidence-based nonpharmacological treatments consistent with the aims of precision medicine, further investigation into novel pharmacological agents, mapping specific psychotic s…
View article: Diagnosis and Management of Alzheimer’s Disease in Primary Care: A Real-World Study in Ontario, Canada
Diagnosis and Management of Alzheimer’s Disease in Primary Care: A Real-World Study in Ontario, Canada Open
Objective: To understand the real-world clinical practice patterns and variation in Alzheimer’s disease (AD) diagnostic and screening tool utilization by primary care physicians (PCPs), including tools used for assessing dementia/AD severi…
View article: Mild Behavioral Impairment and Cortical Thinning: Biomarkers of Early Neurodegeneration
Mild Behavioral Impairment and Cortical Thinning: Biomarkers of Early Neurodegeneration Open
Elevated MBI, particularly abnormal beliefs, is linked to cortical thinning in regions subserving memory, sensory integration, and emotion regulation predominantly in the right hemisphere. These findings highlight the potential of the MBI-…
View article: THE EFFECT OF HEALTH EDUCATION TROUGH SOCIAL MEDIA ON SAFETY BEHAVIOR AMONG MIDWIVES TOWARD SAFE AND HEALTHY CHILBIRTH PROCESS
THE EFFECT OF HEALTH EDUCATION TROUGH SOCIAL MEDIA ON SAFETY BEHAVIOR AMONG MIDWIVES TOWARD SAFE AND HEALTHY CHILBIRTH PROCESS Open
The greatest risk factor for transmission occurs between pregnant women and children, both during childbirth and in infancy, with a risk factor of up to 99%. Neonatal intervention will reduce the risk of transmission from 95% to <5%. Safet…
View article: Pre-psychosis in later life as a risk factor for progressive cognitive decline: Findings from the IPA psychosis in neurodegenerative disease working group
Pre-psychosis in later life as a risk factor for progressive cognitive decline: Findings from the IPA psychosis in neurodegenerative disease working group Open
View article: Mild behavioural impairment-apathy and core Alzheimer's disease cerebrospinal fluid biomarkers
Mild behavioural impairment-apathy and core Alzheimer's disease cerebrospinal fluid biomarkers Open
Apathy is a common neuropsychiatric symptom (NPS) in Alzheimer's disease (AD) but can emerge earlier in prodromal and even preclinical stages as part of mild behavioural impairment (MBI-apathy), a syndrome defined by emergent and persisten…
View article: Red flags for remote cognitive diagnostic assessment: A Delphi expert consensus study by the Canadian Consortium on Neurodegeneration in Aging
Red flags for remote cognitive diagnostic assessment: A Delphi expert consensus study by the Canadian Consortium on Neurodegeneration in Aging Open
Despite the potential benefits of remote cognitive assessment for dementia, it is not appropriate for all clinical encounters. Our aim was to develop guidance on determining a patient's suitability for comprehensive remote cognitive diagno…
View article: Validation of the standard assessment of global everyday activities (SAGEA) scale for dementia diagnosis
Validation of the standard assessment of global everyday activities (SAGEA) scale for dementia diagnosis Open
Background Standardised questionnaires of cognitive symptoms and cognitive-related function can assist in diagnosing dementia. The Standardised Assessment of Global Everyday Activities (SAGEA) is a 15-item questionnaire, developed to measu…
View article: Neuropsychiatric symptoms and progression to pathologically confirmed Alzheimer’s disease
Neuropsychiatric symptoms and progression to pathologically confirmed Alzheimer’s disease Open
Whether or not neuropsychiatric symptoms (NPS) in advance of dementia are associated with Alzheimer’s disease (AD) and/or other neurodegenerative dementias remains to be determined. The mild behavioural impairment (MBI) construct selects p…
View article: Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders
Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders Open
More NPI-C apathy than AES items mapped strongly and uniquely onto the DCA-NCD and its dimensions. The NPI-C apathy may better capture the DCA-NCD and its dimensions compared with the AES.
View article: Cannabis Use Prevalence and Correlates in Patients Attending a Canadian Cognitive Clinic
Cannabis Use Prevalence and Correlates in Patients Attending a Canadian Cognitive Clinic Open
Background: Since cannabis was legalized in Canada in 2018, its use among older adults has increased. Although cannabis may exacerbate cognitive impairment, there are few studies on its use among older adults being evaluated for cognitive …
View article: A Cross Sectional and Longitudinal Assessment of Neuropsychiatric Symptoms and Brain Functional Connectivity in Patients With Mild Cognitive Impairment, Cerebrovascular Disease and Parkinson Disease
A Cross Sectional and Longitudinal Assessment of Neuropsychiatric Symptoms and Brain Functional Connectivity in Patients With Mild Cognitive Impairment, Cerebrovascular Disease and Parkinson Disease Open
Introduction Mild Behavioral Impairment (MBI) is characterized by later‐life emergent and persistent neuropsychiatric symptoms (NPS) in older adults without dementia, serving as a potential precursor to various forms of dementia. This stud…